- Home
- PGEN vs AGD Comparison
PGEN vs AGD Comparison
Compare PGEN & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- AGD
- Stock Information
- Founded
- PGEN 1998
- AGD 2006
- Country
- PGEN United States
- AGD United Kingdom
- Employees
- PGEN N/A
- AGD N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- AGD Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- AGD Finance
- Exchange
- PGEN Nasdaq
- AGD Nasdaq
- Market Cap
- PGEN 292.6M
- AGD 253.4M
- IPO Year
- PGEN N/A
- AGD N/A
- Fundamental
- Price
- PGEN $0.90
- AGD $10.03
- Analyst Decision
- PGEN Buy
- AGD
- Analyst Count
- PGEN 5
- AGD 0
- Target Price
- PGEN $7.00
- AGD N/A
- AVG Volume (30 Days)
- PGEN 858.0K
- AGD 61.2K
- Earning Date
- PGEN 11-14-2024
- AGD 01-01-0001
- Dividend Yield
- PGEN N/A
- AGD 8.13%
- EPS Growth
- PGEN N/A
- AGD N/A
- EPS
- PGEN N/A
- AGD N/A
- Revenue
- PGEN $3,963,000.00
- AGD N/A
- Revenue This Year
- PGEN N/A
- AGD N/A
- Revenue Next Year
- PGEN $211.35
- AGD N/A
- P/E Ratio
- PGEN N/A
- AGD N/A
- Revenue Growth
- PGEN N/A
- AGD N/A
- 52 Week Low
- PGEN $0.77
- AGD $8.20
- 52 Week High
- PGEN $1.93
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- PGEN 52.02
- AGD 35.07
- Support Level
- PGEN $0.77
- AGD $10.30
- Resistance Level
- PGEN $1.05
- AGD $10.23
- Average True Range (ATR)
- PGEN 0.07
- AGD 0.10
- MACD
- PGEN -0.00
- AGD -0.02
- Stochastic Oscillator
- PGEN 47.46
- AGD 5.95
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.